Literature DB >> 3376969

Determining drug dispensing costs for use in cost-accounting systems.

T S Thielke1, J T Charlson, D Heckethorn.   

Abstract

Identification of pharmacy costs to be used in a university hospital's cost-accounting system (CAS) is described. At the University of Wisconsin Hospital and Clinics (UWHC), Madison, standard pharmacy labor times for seven categories of products were developed by determining the pharmacist and technician times for purchasing, ordering, transcribing orders, manufacturing, and distributing and administering medications; pharmacy technicians administer most of the medications to patients at UWHC. The labor cost per dose (standard time multiplied by average wage including fringe benefits) was added to drug acquisition cost, which was obtained from the hospital's computerized formulary. The direct costs associated with drug distribution were identified for use in the hospital CAS. These data can be used to compare the cost-effectiveness of various medication administration schedules; they may also be useful in productivity monitoring and flexible budgeting.

Entities:  

Mesh:

Year:  1988        PMID: 3376969

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  4 in total

1.  The effects of acquisition cost and budget-based compensation on the attitudes of pharmacy directors toward the adoption of a cost-effective new drug.

Authors:  M Kolassa; M C Smith; B F Banahan; D D Garner; W F Shughart
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

2.  Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.

Authors:  R J Lipsy
Journal:  Pharmacoeconomics       Date:  1992-04       Impact factor: 4.981

3.  Decision analysis in formulary decision making.

Authors:  C B Schechter
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

Review 4.  Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach.

Authors:  Ravina Kullar; Eric Wenzler; Jose Alexander; Ellie J C Goldstein
Journal:  Open Forum Infect Dis       Date:  2022-03-21       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.